Cardinal Health, Inc. (CAH): Price and Financial Metrics
GET POWR RATINGS... FREE!
CAH POWR Grades
- CAH scores best on the Growth dimension, with a Growth rank ahead of 97.37% of US stocks.
- The strongest trend for CAH is in Value, which has been heading up over the past 179 days.
- CAH's current lowest rank is in the Sentiment metric (where it is better than 33% of US stocks).
CAH Stock Summary
- Cardinal Health Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 99.79% of US listed stocks.
- CAH's price/sales ratio is 0.09; that's higher than the P/S ratio of merely 0.88% of US stocks.
- CAH's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 98.75% of US stocks.
- Stocks that are quantitatively similar to CAH, based on their financial statements, market capitalization, and price volatility, are CROX, ALJJ, CCLP, POLY, and CAPL.
- Visit CAH's SEC page to see the company's official filings. To visit the company's web site, go to www.cardinalhealth.com.
CAH Valuation Summary
- CAH's EV/EBIT ratio is 36; this is 22.87% higher than that of the median Healthcare stock.
- Over the past 243 months, CAH's price/sales ratio has gone down 0.6.
- CAH's price/sales ratio has moved down 0.6 over the prior 243 months.
Below are key valuation metrics over time for CAH.
CAH Growth Metrics
- The year over year net income to common stockholders growth rate now stands at 127.68%.
- The 2 year net cashflow from operations growth rate now stands at -24.23%.
- Its 3 year cash and equivalents growth rate is now at 32.33%.
The table below shows CAH's growth in key financial areas (numbers in millions of US dollars).
|Date||Revenue||Operating Cash Flow||Net Income to Common Stock|
CAH's Quality FactorsThe “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
- CAH has a Quality Grade of C, ranking ahead of 64.17% of graded US stocks.
- CAH's asset turnover comes in at 3.718 -- ranking 10th of 105 Wholesale stocks.
- AMRK, MCK, and PETQ are the stocks whose asset turnover ratios are most correlated with CAH.
The table below shows CAH's key quality metrics over time.
|Period||Asset Turnover||Gross Margin||ROIC|
CAH Stock Price Chart Interactive Chart >
CAH Price/Volume Stats
|Current price||$57.70||52-week high||$64.53|
|Prev. close||$58.02||52-week low||$45.85|
|Day high||$58.31||Avg. volume||2,908,112|
|50-day MA||$58.60||Dividend yield||3.4%|
|200-day MA||$52.92||Market Cap||15.72B|
Cardinal Health, Inc. (CAH) Company Bio
Cardinal Health provides pharmaceutical and medical products and services that help pharmacies, hospitals and other healthcare providers focus on patient care. The company was founded in 1979 and is based in Dublin, Ohio.
Most Popular Stories View All
CAH Latest News Stream
|Loading, please wait...|
CAH Latest Social Stream
View Full CAH Social Stream
Latest CAH News From Around the Web
Below are the latest news stories about Cardinal Health Inc that investors may wish to consider to help them evaluate CAH as an investment opportunity.
Drug distributors McKesson, AmerisourceBergen and Cardinal Health are part of the settlement.
Drugmaker Johnson & Johnson and three major distributors finalized nationwide settlements over their role in the opioid addiction crisis Friday, an announcement that clears the way for $26 billion to flow to nearly every state and local government in the U.S. Taken together, the settlements are the largest to date among the many opioid-related cases that have been playing out across the country. They''re expected to provide a significant boost to efforts aimed at reversing the crisis in places that have been devastated by it, including many parts of rural America. Johnson & Johnson, AmerisourceBergen, Cardinal Health and McKesson announced the settlement plan last year, but the deal was contingent on getting participation from a critical mass of state and local governments. Friday was t...
The three distributors, McKessen, AmerisourceBergen and Cardinal Health, each "independently determined" that enough states and litigating political subdivisions had signed on to advance the agreement to pay out $19.5 billion over 18 years to thousands of plaintiffs, according to a joint press release from the companies.
BET À DAY Drugmaker Johnson & Johnson and three major distributors (McKessen, AmerisourceBergen and Cardinal Health) confirmed on Friday that they will pay $24.5 billion to end more than 3,000 lawsuits by US states and thousands of communities. In a joint statement, the distributors said they had independently determined that there was “sufficient participation from […] The post Opiate crisis: J&J and 3 distributors agree to pay nearly 25 billion dollars first appeared on The Bobr Times .
Johnson & Johnson (NYSE: JNJ ) shares are trading higher Friday after the company agreed to finalize a proposed $26 billion settlement resolving more than 3,000 lawsuits, mainly by state and local governments, seeking to hold it and three other companies responsible for the opioid abuse crisis. The other companies are distributors McKesson Corp (NYSE: MCK ), AmerisourceBergen Corp (NYSE: ABC ) and Cardinal Health Inc (NYSE: CAH ). Johnson & Johnson was up 4.97% at $166 Friday afternoon at publication. See Also: Drug Distributors, JNJ Agree To Settle $26B Opioid Lawsuits Johnson & Johnson Daily Chart Analysis The stock recently bounced off support in a sideways channel and has been pushing higher, now nearing the resistance level of the channel. Support was found near … Full story availa...
CAH Price Returns
|Ex-Dividend Date||Type||Payout Amount||Change|
|Loading, please wait...|